ATE509276T1 - Diagnostische zusammensetzung für typ-2-diabetes und beeinträchtigte glucosetoleranz sowie verwendungsverfahren - Google Patents

Diagnostische zusammensetzung für typ-2-diabetes und beeinträchtigte glucosetoleranz sowie verwendungsverfahren

Info

Publication number
ATE509276T1
ATE509276T1 AT04761638T AT04761638T ATE509276T1 AT E509276 T1 ATE509276 T1 AT E509276T1 AT 04761638 T AT04761638 T AT 04761638T AT 04761638 T AT04761638 T AT 04761638T AT E509276 T1 ATE509276 T1 AT E509276T1
Authority
AT
Austria
Prior art keywords
diabetes
diagnostic test
type
test meal
glucose tolerance
Prior art date
Application number
AT04761638T
Other languages
English (en)
Inventor
Mark Redmond
Diana Shaw
Original Assignee
Ceapro Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceapro Inc filed Critical Ceapro Inc
Application granted granted Critical
Publication of ATE509276T1 publication Critical patent/ATE509276T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04761638T 2003-08-13 2004-08-16 Diagnostische zusammensetzung für typ-2-diabetes und beeinträchtigte glucosetoleranz sowie verwendungsverfahren ATE509276T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49454903P 2003-08-13 2003-08-13
PCT/CA2004/001474 WO2005017532A1 (en) 2003-08-13 2004-08-16 Diagnostic composition for diabetes type-2 and impaired glucose tolerance, and methods of use

Publications (1)

Publication Number Publication Date
ATE509276T1 true ATE509276T1 (de) 2011-05-15

Family

ID=34193221

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04761638T ATE509276T1 (de) 2003-08-13 2004-08-16 Diagnostische zusammensetzung für typ-2-diabetes und beeinträchtigte glucosetoleranz sowie verwendungsverfahren

Country Status (7)

Country Link
US (1) US20060188443A1 (de)
EP (1) EP1660889B1 (de)
CN (1) CN100595587C (de)
AT (1) ATE509276T1 (de)
ES (1) ES2365138T3 (de)
RU (1) RU2348040C2 (de)
WO (1) WO2005017532A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656838A4 (de) * 2003-08-21 2007-10-24 Abilit Corp Nahrungsmittel zum testen von krankheiten, die mit dem lebenswandel in zusammenhang stehen
AU2008261526A1 (en) * 2007-06-13 2008-12-18 The Governors Of The University Of Alberta High viscosity beta-glucan products and methods of preparation
AU2008270671B2 (en) * 2007-06-28 2011-01-20 Kraft Foods Global Brands Llc In vitro method for the determination of glycemic index of food products
US9245263B2 (en) 2009-06-23 2016-01-26 Jwl Ip Holdings Llc Systems and methods for scripted content delivery
CA2766870A1 (en) * 2009-06-30 2011-01-06 Lifescan Scotland Limited Systems for diabetes management and methods
CA2766944C (en) * 2009-06-30 2019-10-29 Lifescan, Inc. Analyte testing methods and device for calculating basal insulin therapy
WO2011112074A1 (en) 2010-03-11 2011-09-15 N.V. Nutricia Novel glucose tolerance test and composition for use
KR101226824B1 (ko) * 2010-07-29 2013-01-25 경북대학교 산학협력단 수수 추출물을 유효성분으로 함유하는 당뇨병 예방 및 치료용 약학조성물
JP5815362B2 (ja) * 2011-10-17 2015-11-17 シスメックス株式会社 耐糖能分析装置、耐糖能分析システム及びコンピュータプログラム
CN103404789B (zh) * 2012-07-05 2015-04-01 中粮营养健康研究院有限公司 面条和标准餐以及它们在糖尿病检测诊断中的应用
RU2557978C2 (ru) * 2013-07-22 2015-07-27 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения Российской Федерации Способ диагностики гестационного сахарного диабета
CN105277705A (zh) * 2014-07-24 2016-01-27 江苏维赛科技生物发展有限公司 一种检测双胍类药物残留的试剂盒的制备及其检测方法
RU2596506C1 (ru) * 2015-03-13 2016-09-10 Общество С Ограниченной Ответственностью "Хилби" Способ определения гликемического индекса потребляемой человеком пищи
RU2589663C1 (ru) * 2015-05-05 2016-07-10 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ прогноза риска развития гестационного сахарного диабета
US11986288B2 (en) * 2017-03-06 2024-05-21 Medtronic Minimed, Inc. Colorometric sensor for the non-invasive screening of glucose in sweat in pre and type 2 diabetes
CN108522602A (zh) * 2018-04-10 2018-09-14 光谷迈德（武汉）慢性病研究院有限公司 一种可用于糖耐量试验的饼干标准餐及其制备方法
RU2703342C1 (ru) * 2018-11-19 2019-10-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации Прогнозирование развития гестационного сахарного диабета у первородящих юного возраста
WO2020148363A1 (en) 2019-01-18 2020-07-23 Boehringer Ingelheim Vetmedica Gmbh Oral composition comprising saccharides for the diagnosis of insulin dysregulation in equines and methods of use thereof
CN116507215A (zh) * 2020-07-23 2023-07-28 塞玛尔有限公司 测试餐、测试餐包装物及其方法和用途
CN118511995B (zh) * 2024-07-25 2024-10-22 江西中医药大学 一种具有改善糖代谢紊乱的多糖组合物及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435429A (en) * 1982-02-16 1984-03-06 Canadian Patents And Development Limited Processing aqueous treated cereals
US4496606A (en) * 1983-04-29 1985-01-29 Nabisco Brands, Inc. Guar gum food bar
US5422136A (en) * 1987-04-20 1995-06-06 Fuisz Technologies Ltd. Starch-based food enhancing ingredient
US5200215A (en) * 1988-04-20 1993-04-06 Nabisco, Inc. Enzyme treated low moisture content comestible products
SE466157B (sv) * 1989-04-25 1992-01-07 Migrata Uk Ltd Saett att bestaemma glukoshalten hos helblod samt engaangskuvett foer detta
CA2013190C (en) * 1990-03-27 2000-06-06 F. William Collins Method of producing stable bran and flour products from cereal grains
US5360614A (en) * 1993-04-26 1994-11-01 The Estee Corporation Method of controlling the release of carbohydrates by encapsulation and composition therefor
US5545414A (en) * 1995-03-22 1996-08-13 Abbott Laboratories Cholesterol lowering food product
US5579580A (en) * 1995-03-31 1996-12-03 Warner-Lambert Company Bi-directional wire-wrapped blade cartridge
CA2225283C (en) * 1995-06-30 2007-11-27 Ceapro Inc. Solid oral diagnostic test meal and methods of use thereof
ATE188132T1 (de) * 1995-07-06 2000-01-15 Disetronic Licensing Ag Einweg-kassette zum anschliessen an eine infusionspumpe für ein flüssiges arzneimittel
US5612074A (en) * 1995-12-21 1997-03-18 Leach; Robin L. Nutrient fortified food bar
CN1155394A (zh) * 1996-01-25 1997-07-30 葛林龙 组合餐用糖源-白金糖、黄金糖、纯金糖、合金糖
US6248375B1 (en) * 2000-03-14 2001-06-19 Abbott Laboratories Diabetic nutritionals and method of using
US20020132279A1 (en) * 2000-05-30 2002-09-19 Linda Hockersmith Formula to manipulate blood glucose via the calculated ingestion of carbohydrate

Also Published As

Publication number Publication date
CN100595587C (zh) 2010-03-24
US20060188443A1 (en) 2006-08-24
WO2005017532A1 (en) 2005-02-24
EP1660889A4 (de) 2008-08-13
CN1836167A (zh) 2006-09-20
EP1660889B1 (de) 2011-05-11
ES2365138T3 (es) 2011-09-23
EP1660889A1 (de) 2006-05-31
RU2006106789A (ru) 2006-08-10
RU2348040C2 (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
Norris et al. Long‐term non‐pharmacological weight loss interventions for adults with prediabetes
Sacco et al. Depression in adults with type 2 diabetes: the role of adherence, body mass index, and self-efficacy.
Renard Monitoring glycemic control: the importance of self-monitoring of blood glucose
Wien et al. Almonds vs complex carbohydrates in a weight reduction program
Hamdy et al. The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes
WO1997002050A3 (en) Solid oral diagnostic test meal and methods of use thereof
Huffman et al. A positive psychology-motivational interviewing program to promote physical activity in type 2 diabetes: The BEHOLD-16 pilot randomized trial
Watson et al. Diabetes connected health: a pilot study of a patient-and provider-shared glucose monitoring web application
Kausar et al. Effect of apple cider vinegar in type 2 diabetic patients with poor glycemic control: a randomized placebo controlled design®
Ferrer-García et al. Benefits of a home-based physical exercise program in elderly subjects with type 2 diabetes mellitus
Belmonte et al. Impact of SMBG on control of diabetes as measured by HbA1: 3-yr survey of a juvenile IDDM clinic
Wilson et al. Treatment satisfaction after commencement of insulin in Type 2 diabetes
Kordowski et al. A nutritional supplement based on a synbiotic combination of Bacillus subtilis DSM 32315 and L-alanyl-L-glutamine improves glucose metabolism in healthy prediabetic subjects–A real-life post-marketing study
Trenell et al. A pathway to type 2 diabetes remission: Weight reduction and A1C improvements are facilitated by a low-calorie diet including diabetes-specific nutritional formula and the use of digitally enabled reinforcement
Lin et al. Lifestyle characteristics as moderators of the effectiveness of weight control interventions among semiconductor workers
Jabbar et al. How well do Pakistani patients and physicians adhere to standards of diabetes care?
Rumaolat et al. The effect of progressive muscle relaxation on reducing stress and blood sugar in type 2 diabetes mellitus patients in the work area of Taniwel Public Health Center
Tekin et al. Cognitive impairment among type-2 diabetic subjects and its relationship with long-term complications
Trask et al. Safety and efficacy of the nonsystemic chewable complex carbohydrate dietary supplement PAZ320 on postprandial glycemia when added to oral agents or insulin in patients with type 2 diabetes mellitus
Lai et al. Physical activity and quality of life in patients with type II diabetes mellitus
Banks et al. The effect of insulin on post-exercise hypoglycemia in adults with type 2 diabetes participating in outpatient exercise-based cardiac rehabilitation
Chaudhry et al. Reduced-exertion high-intensity interval training (REHIT) provides limited improvement in post-prandial and 24-hour glycemia in healthy, physically active men
Lakdawala et al. Most frequently observed oral complications in patients with diabetes Mellitus
Venter et al. Evaluation of Quality of Life in Patients with Metabolic Syndrome and Risk of Sleep Apnea Using SF-36 Short Form.
Gomez-Peralta et al. Glycemic Control and Hospital Admission Risk in Type 1 Diabetes is Related to the Use of Carbohydrate Counting and Frequency of Self-Monitoring of Blood Glucose: RSD1 Study

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties